Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Oct 3;21(12):2185–2192. doi: 10.1158/1055-9965.EPI-12-0792-T

Table 3.

Risk of distal gastric cancer by number of sero-positives to 6 H. pylori proteins (Omp, HP0305, HyuA, HpaA, CagA, and VacA) for each individual, in the SMHS

All Excluding cases diagnosed within 2 years after recruitment and matched controls

No. sero-positive Cases n (%) Controls n (%) Matched OR* (95% CI) Cases n (%) Controls n (%) Matched OR* (95% CI)
All
0–3 29 (12.8) 114 (25.3) 1.00 (Reference) 17 (10.8) 85 (26.9) 1.00 (Reference)
4–5 141 (62.4) 273 (60.5) 2.08 (1.31, 3.30) 105 (66.5) 188 (59.5) 2.79 (1.56, 4.96)
6 56 (24.8) 64 (14.2) 3.49 (2.00, 6.11) 36 (22.8) 43 (13.6) 4.16 (2.08, 8.32)
P for trend <0.0001 <0.0001
*

odds ratios from a conditional logistic regression model, cases and controls matched on age (within 2 years), date (within 30 days) and time (morning or afternoon) of sample collection, time interval since last meal (within 2 hours), and antibiotic use in the past week (yes/no).